Catalyst Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of this webpage for potential risks for Catalyst Pharmaceuticals Inc based on industry, geography and size. The page contains a free E,S&G assessment for Catalyst Pharmaceuticals Inc. The article contains a questions and answers table on Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.0, social score of 4.8 and governance score of 6.4.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| 724 | Kinnate Biopharma Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Catalyst Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Catalyst Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Catalyst Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Catalyst Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Catalyst Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Catalyst Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Catalyst Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.